Skip to main content
Premium Trial:

Request an Annual Quote

Whitehead Licenses Reverse Transfection Patent Rights to Corning

NEW YORK, Aug. 3 (GenomeWeb News) - The Whitehead Institute for Biomedical Research has granted Corning Life Sciences a license for the patent rights to its reverse transfection technology, Corning said yesterday.


Corningwill pair the microarray-based method for the functional analysis in mammalian cells of many genes in parallel with other technology to enhance its molecular and cell culture applications.


A spokesperson for the Whitehead said the technology could be useful in drug screening and development, though a representative from Corning declined to comment on possible future applications.


Financial details were not discussed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.